Cushing's syndrome induced by topical steroids used for the treatment of non-bullous ichthyosiform erythroderma.
D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003480:Cushing Syndrome / Q000139:chemically induced*; D004643:Emollients / Q000627:therapeutic use; D005260:Female; D005446:Fluocinolone Acetonide / Q000009:adverse effects*; D006801:Humans; D007057:Ichthyosis / Q000188:drug therapy*; D007223:Infant; D008297:Male; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy*
D004643:Emollients; D005446:Fluocinolone Acetonide; D001623:Betamethasone; D001624:Betamethasone Valerate